TY - JOUR
T1 - Novel approaches to decrease inappropriate ambulatory antibiotic use
AU - Rowe, Theresa A.
AU - Linder, Jeffrey A.
N1 - Funding Information:
J Linder is supported by grants from the National Institute on Aging (R21AG057400, R21AG057396, R21AG057383), National Institute on Drug Abuse (R21AG057395), Agency for Healthcare Research and Quality (R01HS024930, R01HS026506), The Gordon and Betty More Foundation, The Peterson Center on Healthcare, and a contract from the Agency for Healthcare Research and Quality (HHSP2332015000201). T Rowe is supported by grants from the National Institute on Aging (R21AG057383) and a contract from the Agency for Healthcare Research and Quality (HHSP2332015000201). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Publisher Copyright:
© 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2019/7/3
Y1 - 2019/7/3
N2 - Introduction: Inappropriate antibiotic use and antibiotic resistance are major public health threats. In the United States, most antibiotic use occurs in ambulatory care and 30% to 50% may be inappropriate. The National Action Plan for Combating Antibiotic-Resistant Bacteria set a goal of reducing inappropriate outpatient antibiotics by 50% by 2020. Areas covered: This review summarizes the epidemiology of antibiotic use in ambulatory care and explores evidence-based, novel approaches for improving ambulatory antibiotic use. Expert opinion: We leveraged insights from behavioral science and social psychology to implement novel peer comparison–a form of audit-and-feedback–and accountable justification alert interventions that reduced inappropriate antibiotic prescribing to 5% or less. We and others have been successful in reducing inappropriate antibiotic prescribing with precommitment posters, communication training, combined patient/clinician education, and clinical decision support. Other commonly employed, but unsound approaches to reducing inappropriate antibiotic prescribing include point-of-care testing and delayed antibiotic prescriptions. These approaches are not durable (e.g. CRP testing), have not been proven in primary care (e.g. procalcitonin), or are conceptually flawed, such as using testing for non-antibiotic-appropriate diagnoses or using delayed antibiotic prescriptions. To decrease inappropriate ambulatory antibiotic use, clinicians, pharmacists, practices, and health systems need to collect antibiotic prescribing data, select concrete improvement targets, and implement evidence-based interventions such as peer comparison, accountable justification, precommitment, and communication training.
AB - Introduction: Inappropriate antibiotic use and antibiotic resistance are major public health threats. In the United States, most antibiotic use occurs in ambulatory care and 30% to 50% may be inappropriate. The National Action Plan for Combating Antibiotic-Resistant Bacteria set a goal of reducing inappropriate outpatient antibiotics by 50% by 2020. Areas covered: This review summarizes the epidemiology of antibiotic use in ambulatory care and explores evidence-based, novel approaches for improving ambulatory antibiotic use. Expert opinion: We leveraged insights from behavioral science and social psychology to implement novel peer comparison–a form of audit-and-feedback–and accountable justification alert interventions that reduced inappropriate antibiotic prescribing to 5% or less. We and others have been successful in reducing inappropriate antibiotic prescribing with precommitment posters, communication training, combined patient/clinician education, and clinical decision support. Other commonly employed, but unsound approaches to reducing inappropriate antibiotic prescribing include point-of-care testing and delayed antibiotic prescriptions. These approaches are not durable (e.g. CRP testing), have not been proven in primary care (e.g. procalcitonin), or are conceptually flawed, such as using testing for non-antibiotic-appropriate diagnoses or using delayed antibiotic prescriptions. To decrease inappropriate ambulatory antibiotic use, clinicians, pharmacists, practices, and health systems need to collect antibiotic prescribing data, select concrete improvement targets, and implement evidence-based interventions such as peer comparison, accountable justification, precommitment, and communication training.
KW - Ambulatory care
KW - anti-bacterial agents
KW - antimicrobial stewardship
KW - bacterial
KW - behavioral
KW - clinical decision making
KW - drug resistance
KW - economics
UR - http://www.scopus.com/inward/record.url?scp=85068688135&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85068688135&partnerID=8YFLogxK
U2 - 10.1080/14787210.2019.1635455
DO - 10.1080/14787210.2019.1635455
M3 - Review article
C2 - 31232615
AN - SCOPUS:85068688135
SN - 1478-7210
VL - 17
SP - 511
EP - 521
JO - Expert Review of Anti-Infective Therapy
JF - Expert Review of Anti-Infective Therapy
IS - 7
ER -